(ELF) ELF Beauty - Overview

Sector: Consumer Defensive | Industry: Household & Personal Products | Exchange: NYSE (USA) | Market Cap: 3.233m USD | Total Return: -36.1% in 12m

Cosmetics, Skin Care, Makeup Brushes
Total Rating 40
Safety 71
Buy Signal -0.89
Household & Personal Products
Industry Rotation: +8.8
Market Cap: 3.23B
Avg Turnover: 162M
Risk 3d forecast
Volatility67.4%
VaR 5th Pctl10.8%
VaR vs Median-3.36%
Reward TTM
Sharpe Ratio-0.25
Rel. Str. IBD1.4
Rel. Str. Peer Group7.9
Character TTM
Beta1.364
Beta Downside1.436
Hurst Exponent0.561
Drawdowns 3y
Max DD77.09%
CAGR/Max DD-0.26
CAGR/Mean DD-0.55
EPS (Earnings per Share) EPS (Earnings per Share) of ELF over the last years for every Quarter: "2021-03": 0.16, "2021-06": 0.27, "2021-09": 0.21, "2021-12": 0.24, "2022-03": 0.13, "2022-06": 0.39, "2022-09": 0.36, "2022-12": 0.48, "2023-03": 0.42, "2023-06": 1.1, "2023-09": 0.82, "2023-12": 0.74, "2024-03": 0.53, "2024-06": 1.1, "2024-09": 0.77, "2024-12": 0.74, "2025-03": 0.78, "2025-06": 0.89, "2025-09": 0.68, "2025-12": 1.24, "2026-03": null,
EPS CAGR: 18.66%
EPS Trend: 74.1%
Last SUE: 4.00
Qual. Beats: 1
Revenue Revenue of ELF over the last years for every Quarter: 2021-03: 92.671, 2021-06: 97.047, 2021-09: 91.855, 2021-12: 98.118, 2022-03: 105.135, 2022-06: 122.601, 2022-09: 122.349, 2022-12: 146.537, 2023-03: 187.357, 2023-06: 216.339, 2023-09: 215.507, 2023-12: 270.943, 2024-03: 321.143, 2024-06: 324.477, 2024-09: 301.075, 2024-12: 355.32, 2025-03: 332.645, 2025-06: 353.739, 2025-09: 343.936, 2025-12: 489.505, 2026-03: 449.292,
Rev. CAGR: 33.98%
Rev. Trend: 96.0%
Last SUE: 1.44
Qual. Beats: 2

Warnings

P/E ratio 123.6

Fakeout

Tailwinds

No distinct edge detected

Description: ELF ELF Beauty

e.l.f. Beauty, Inc. (ELF) is an Oakland-based cosmetics and skincare company that develops and markets affordable beauty products globally. Its portfolio includes brands such as e.l.f. Cosmetics, e.l.f. Skin, Well People, Naturium, and Keys Soulcare. The company utilizes an omni-channel distribution strategy, leveraging national retail partnerships alongside a direct-to-consumer e-commerce platform.

The company operates within the mass-market beauty segment, a business model characterized by high inventory turnover and rapid product innovation cycles to mirror prestige trends at lower price points. This sector is increasingly driven by clean beauty standards, focusing on vegan and cruelty-free formulations to align with shifting consumer preferences. For a deeper look into the companys valuation metrics, consider reviewing the latest data on ValueRay.

Headlines to Watch Out For
  • Market share gains driven by value-priced alternatives to prestige beauty brands
  • International retail expansion accelerates revenue growth beyond North American core markets
  • Naturium acquisition integration scales skincare portfolio and improves consolidated gross margins
  • Social media marketing efficiency sustains high brand engagement among Gen Z consumers
  • Shelf space expansion with major retailers like Target and Walmart boosts volume
Piotroski VR‑10 (Strict) 3.5
Net Income: 26.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.30 > 1.0
NWC/Revenue: 27.69% < 20% (prev 27.67%; Δ 0.02% < -1%)
CFO/TA 0.09 > 3% & CFO 212.5m > Net Income 26.3m
Net Debt (699.0m) to EBITDA (185.5m): 3.77 < 3
Current Ratio: 2.35 > 1.5 & < 3
Outstanding Shares: last quarter (59.9m) vs 12m ago 2.74% < -2%
Gross Margin: 70.72% > 18% (prev 0.71%; Δ 7.00k% > 0.5%)
Asset Turnover: 89.86% > 50% (prev 105.2%; Δ -15.38% > 0%)
Interest Coverage Ratio: 3.72 > 6 (EBITDA TTM 185.5m / Interest Expense TTM 35.3m)
Altman Z'' 1.39
A: 0.19 (Total Current Assets 789.4m - Total Current Liabilities 336.2m) / Total Assets 2.39b
B: -0.07 (Retained Earnings -155.9m / Total Assets 2.39b)
C: 0.07 (EBIT TTM 131.3m / Avg Total Assets 1.82b)
D: -0.12 (Book Value of Equity -154.5m / Total Liabilities 1.26b)
Altman-Z'' = 1.39 = BB
Beneish M -2.71
DSRI: 1.11 (Receivables 174.6m/126.0m, Revenue 1.64b/1.31b)
GMI: 1.01 (GM 70.72% / 71.24%)
AQI: 1.20 (AQ_t 0.65 / AQ_t-1 0.54)
SGI: 1.25 (Revenue 1.64b / 1.31b)
TATA: -0.08 (NI 26.3m - CFO 212.5m) / TA 2.39b)
Beneish M = -2.71 (Cap -4..+1) = A
What is the price of ELF shares? As of May 23, 2026, the stock is trading at USD 53.12 with a total of 9,762,949 shares traded.
Over the past week, the price has changed by -6.26%, over one month by -19.34%, over three months by -41.27% and over the past year by -36.10%.
Is ELF a buy, sell or hold? ELF Beauty has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy ELF.
  • StrongBuy: 9
  • Buy: 3
  • Hold: 5
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the ELF price?
Analysts Target Price 87.7 65%
ELF Beauty (ELF) - Fundamental Data Overview as of 23 May 2026
P/E Trailing = 123.6136
P/E Forward = 14.7059
P/S = 12.0469
P/B = 2.7929
P/EG = 1.3707
Revenue TTM = 1.64b USD
EBIT TTM = 131.3m USD
EBITDA TTM = 185.5m USD
Long Term Debt = 816.7m USD (from longTermDebt, two quarters ago)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 988.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 79.4m
Net Debt = 699.0m USD (calculated: Debt 988.7m - CCE 289.7m)
Enterprise Value = 3.93b USD (3.23b + Debt 988.7m - CCE 289.7m)
Interest Coverage Ratio = 3.72 (Ebit TTM 131.3m / Interest Expense TTM 35.3m)
EV/FCF = 20.69x (Enterprise Value 3.93b / FCF TTM 190.1m)
FCF Yield = 4.83% (FCF TTM 190.1m / Enterprise Value 3.93b)
FCF Margin = 11.61% (FCF TTM 190.1m / Revenue TTM 1.64b)
Net Margin = 1.61% (Net Income TTM 26.3m / Revenue TTM 1.64b)
Gross Margin = 70.72% ((Revenue TTM 1.64b - Cost of Revenue TTM 479.1m) / Revenue TTM)
Gross Margin QoQ = 72.66% (prev 70.99%)
Tobins Q-Ratio = 1.64 (Enterprise Value 3.93b / Total Assets 2.39b)
Interest Expense / Debt = 1.13% (Interest Expense 11.1m / Debt 988.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 103.7m (EBIT 131.3m * (1 - 21.00%))
Current Ratio = 2.35 (Total Current Assets 789.4m / Total Current Liabilities 336.2m)
Debt / Equity = 0.87 (Debt 988.7m / totalStockholderEquity, last quarter 1.13b)
Debt / EBITDA = 3.77 (Net Debt 699.0m / EBITDA 185.5m)
Debt / FCF = 3.68 (Net Debt 699.0m / FCF TTM 190.1m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.45% (Net Income 26.3m / Total Assets 2.39b)
RoE = 2.17% (Net Income TTM 26.3m / Total Stockholder Equity 1.21b)
RoCE = 6.46% (EBIT 131.3m / Capital Employed (Equity 1.21b + L.T.Debt 816.7m))
RoIC = 5.77% (NOPAT 103.7m / Invested Capital 1.80b)
WACC = 8.46% (E(3.23b)/V(4.22b) * Re(10.78%) + D(988.7m)/V(4.22b) * Rd(1.13%) * (1-Tc(0.21)))
Discount Rate = 10.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 28.89 | Cagr: 1.45%
[DCF] Terminal Value 80.09% ; FCFF base≈160.2m ; Y1≈197.6m ; Y5≈337.1m
[DCF] Fair Price = 77.16 (EV 5.29b - Net Debt 699.0m = Equity 4.59b / Shares 59.4m; r=8.46% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 74.10 | EPS CAGR: 18.66% | SUE: 4.0 | # QB: 1
Revenue Correlation: 96.02 | Revenue CAGR: 33.98% | SUE: 1.44 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.83 | Chg30d=-18.36% | Revisions=-38% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.62 | Chg30d=-11.59% | Revisions=-23% | Analysts=2
EPS current Year (2027-03-31): EPS=3.37 | Chg30d=-7.45% | Revisions=-27% | GrowthEPS=+7.6% | GrowthRev=+14.7%
EPS next Year (2028-03-31): EPS=3.99 | Chg30d=-2.81% | Revisions=-33% | GrowthEPS=+18.4% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: -38%